These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Coagulation pathways: interrelationships and control mechanisms. Bennett B Semin Hematol; 1977 Jul; 14(3):301-18. PubMed ID: 69320 [No Abstract] [Full Text] [Related]
3. The role of the liver in biosynthesis of the non-vitamin K-dependent clotting factors. Workman EF; Lundblad RL Semin Thromb Hemost; 1977; 4(1):15-28. PubMed ID: 72415 [No Abstract] [Full Text] [Related]
4. [Hemostatic mechanisms and malignant tumors]. Kase F; Pospísil J; Hlousková D Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):809-30. PubMed ID: 2419210 [TBL] [Abstract][Full Text] [Related]
5. The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium. Beller FK; Ebert C Eur J Obstet Gynecol Reprod Biol; 1982 May; 13(3):177-97. PubMed ID: 6178627 [No Abstract] [Full Text] [Related]
6. Theories of blood coagulation. Properties and interactions of blood clotting factors. Kazal LA Ann Clin Lab Sci (1971); 1971; 1(2):139-54. PubMed ID: 4949446 [No Abstract] [Full Text] [Related]
7. Some recent advances in the study of hemostasis. Ratnoff OD Circ Res; 1974 Jul; 35(1):1-14. PubMed ID: 4601719 [No Abstract] [Full Text] [Related]
8. [An analysis of disseminated intravascular coagulation by fibrinopeptides]. Gando S; Tedo I Rinsho Ketsueki; 1988 Dec; 29(12):2250-5. PubMed ID: 3150013 [No Abstract] [Full Text] [Related]
9. A clotting artifact in isolated rat liver perfusions. Owen CA; Bowie EJ Thromb Res; 1975 Nov; 7(5):765-75. PubMed ID: 1209560 [No Abstract] [Full Text] [Related]
10. Fibrin polymerization sites in fibrinogen and fibrin fragments. Budzynski AZ; Olexa SA; Pandya BV Ann N Y Acad Sci; 1983 Jun; 408():301-14. PubMed ID: 6575691 [No Abstract] [Full Text] [Related]
11. Hypercoagulation and thrombosis. Penner JA Med Clin North Am; 1980 Jul; 64(4):743-59. PubMed ID: 6772892 [TBL] [Abstract][Full Text] [Related]
12. [Molecular markers of hemostatic mechanisms--fibrinopeptide A and fibrinopeptide B beta 15-42]. Kobayashi N Rinsho Byori; 1989 Mar; 37(3):231-3. PubMed ID: 2746916 [No Abstract] [Full Text] [Related]
14. Markers of fibrinogen derivatives used in clinical investigation. Soria J; Soria C; Mirshahi M; Samama MM Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296 [No Abstract] [Full Text] [Related]
15. The occurrence and clinical relevance of fibrin fragments in blood. Gaffney PJ Ann N Y Acad Sci; 1983 Jun; 408():407-23. PubMed ID: 6575697 [No Abstract] [Full Text] [Related]
16. Activation of blood coagulation and fibrinolysis in Graves' disease. Marongiu F; Conti M; Murtas ML; Mameli G; Sorano GG; Martino E Horm Metab Res; 1991 Dec; 23(12):609-11. PubMed ID: 1778596 [TBL] [Abstract][Full Text] [Related]
17. Fibrinogen derivatives in plasma. Lane DA Br J Haematol; 1981 Mar; 47(3):329-35. PubMed ID: 6161635 [No Abstract] [Full Text] [Related]
18. A two-step fibrinogen--fibrin transition in blood coagulation. Blombäck B; Hessel B; Hogg D; Therkildsen L Nature; 1978 Oct; 275(5680):501-5. PubMed ID: 692730 [TBL] [Abstract][Full Text] [Related]
19. Inhibitors of coagulation-fibrinolysis system and platelet function in patients with vertigo. Noda Y; Nakamura M; Sasaki M; Kosugi T Auris Nasus Larynx; 1986; 13 Suppl 1():S75-9. PubMed ID: 2429647 [TBL] [Abstract][Full Text] [Related]
20. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis. Laudes IJ; Chu JC; Sikranth S; Huber-Lang M; Guo RF; Riedemann N; Sarma JV; Schmaier AH; Ward PA Am J Pathol; 2002 May; 160(5):1867-75. PubMed ID: 12000738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]